MicroRNA-29c Enhances the Sensitivities of Human Nasopharyngeal Carcinoma to Cisplatin-Based Chemotherapy and Radiotherapy

Jia-Xing Zhang,Dong Qian,Feng-Wei Wang,Ding-Zhun Liao,Jin-Huan Wei,Zhu-Ting Tong,Jia Fu,Xiao-Xia Huang,Yi-Ji Liao,Hai-Xia Deng,Yi-Xin Zeng,Dan Xie,Shi-Juan Mai
DOI: https://doi.org/10.1016/j.canlet.2012.10.033
IF: 9.756
2013-01-01
Cancer Letters
Abstract:This study was aimed to investigate the potential role of microRNA-29c (miR-29c) in regulating the sensitivities of nasopharyngeal carcinoma (NPC) to ionizing radiation (IR) and cisplatin. Low expression of miR-29c was positively associated with therapeutic resistance in 159 NPC cases. Our further in vitro and in vivo studies illustrated ectopic restoration of miR-29c substantially enhanced the sensitivity of NPC cells to IR and cisplatin treatment by promoting apoptosis. Furthermore, we detected miR-29c repressed expression of anti-apoptotic factors, Mcl-1 and Bcl-2 in NPC tissues and cell lines. These data indicate miR-29c might serve as a potential therapeutic sensitizer in NPC treatment.
What problem does this paper attempt to address?